MLchartDataset catalogue

maytansinoid DM4-conjugated humanized monoclonal antibody huC242

Term · Oncology and biomedicine · MLC-T-ONC-005167

A substance being studied in the treatment of some types of cancer. It is made by linking the monoclonal antibody huC242 to a toxic substance called maytansinoid DM4. The monoclonal antibody binds to the surfaces of cancer cells and the maytansinoid DM4 enters the cells and blocks their growth. It is a type of immunotoxin. Also called huC242-DM4.

Table 1. Record
IdentifierMLC-T-ONC-005167
FieldOncology and biomedicine
SynonymshuC242-DM4
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-005167",
  "term": "maytansinoid DM4-conjugated humanized monoclonal antibody huC242",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of some types of cancer. It is made by linking the monoclonal antibody huC242 to a toxic substance called maytansinoid DM4. The monoclonal antibody binds to the surfaces of cancer cells and the maytansinoid DM4 enters the cells and blocks their growth. It is a type of immunotoxin. Also called huC242-DM4.",
  "synonyms": [
    "huC242-DM4"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/maytansinoid-dm4-conjugated-humanized-monoclonal-antibody-huc242/"
}

Record 10,686 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.